Fig. 1From: PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancerA Nomogram for predicting tumor residual risk in cervical cancer underwent radiotherapy. B Receiver operating characteristic curve (ROC) of nomogram and variables for prediction residual tumor in cervical cancer. C Calibration plot of the predicted and observed probabilities of residual tumor. SCC, squamous cell carcinoma; AC, adenocarcinomaBack to article page